Flex Pharma (FLKS) Short Interest Ratio & Short Volume → Could Bitcoin Literally FORCE This Crypto To Rocket Up? (From Paradigm Press) (Ad) Free FLKS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisCompetitorsSocial MediaStock AnalysisCompetitorsSocial Media Flex Pharma Short Interest DataCurrent Short Volume749,000 sharesPrevious Short Volume942,700 sharesChange Vs. Previous Month-20.55%Dollar Volume Sold Short$414,047.20Short Interest Ratio / Days to Cover0.7Last Record DateJune 30, 2019Outstanding Shares18,070,000 sharesFloat Size14,250,000 sharesShort Percent of Float5.26%Today's Trading Volume105,627 sharesAverage Trading Volume2,030,504 sharesToday's Volume Vs. Average5% Short Selling Flex Pharma ? Sign up to receive the latest short interest report for Flex Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatFLKS Short Interest Over TimeFLKS Days to Cover Over TimeFLKS Percentage of Float Shorted Over Time Ad Paradigm PressCould Bitcoin Literally FORCE This Crypto To Rocket Up?Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. Flex Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/30/2019749,000 shares $414,047.20 -20.6%5.3%0.7 $0.55 5/15/2019851,200 shares $348,992.00 -15.0%5.4%0.7 $0.41 FLKS Short Interest - Frequently Asked Questions What is Flex Pharma's current short interest? Short interest is the volume of Flex Pharma shares that have been sold short but have not yet been covered or closed out. As of June 30th, traders have sold 749,000 shares of FLKS short. 5.26% of Flex Pharma's shares are currently sold short. Learn More on Flex Pharma's current short interest. What is a good short interest ratio for Flex Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FLKS shares currently have a short interest ratio of 1.0. Learn More on Flex Pharma's short interest ratio. What is a good short interest percentage for Flex Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 5.26% of Flex Pharma's floating shares are currently sold short. Is Flex Pharma's short interest increasing or decreasing? Flex Pharma saw a decrease in short interest in the month of June. As of June 30th, there was short interest totaling 749,000 shares, a decrease of 20.5% from the previous total of 942,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Flex Pharma's float size? Flex Pharma currently has issued a total of 18,070,000 shares. Some of Flex Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Flex Pharma currently has a public float of 14,250,000 shares. How does Flex Pharma's short interest compare to its competitors? 5.26% of Flex Pharma's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Flex Pharma: Adial Pharmaceuticals, Inc. (0.24%), Molecular Templates, Inc. (1.15%), Akari Therapeutics, Plc (0.16%), Longeveron Inc. (3.10%), Biofrontera Inc. (0.95%), Hepion Pharmaceuticals, Inc. (1.47%), Galera Therapeutics, Inc. (4.07%), Virios Therapeutics, Inc. (1.13%), Aeterna Zentaris Inc. (0.45%), Cyclerion Therapeutics, Inc. (1.18%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Electronics For Imaging, Inc. ($108.67 million), OHR Pharmaceutical Inc ($968,440.00), and Flex Pharma Inc ($414,047.20). View all of the most shorted stocks. What does it mean to sell short Flex Pharma stock? Short selling FLKS is an investing strategy that aims to generate trading profit from Flex Pharma as its price is falling. FLKS shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Flex Pharma? A short squeeze for Flex Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FLKS, which in turn drives the price of the stock up even further. How often is Flex Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FLKS, twice per month. The most recent reporting period available is June, 30 2019. More Short Interest Resources from MarketBeat Related Companies: Adial Pharmaceuticals Short Squeeze Molecular Templates Short Squeeze Akari Therapeutics Short Squeeze Longeveron Short Squeeze Biofrontera Short Squeeze Hepion Pharmaceuticals Short Squeeze Galera Therapeutics Short Squeeze Virios Therapeutics Short Squeeze Aeterna Zentaris Short Squeeze Cyclerion Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FLKS) was last updated on 4/18/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsThe “Perfect Storm” for GoldGold Safe ExchangeUrgent alert: open this for a huge profit potentialTimothy SykesTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsBiden out June 13; Kamala won’t replace him?Paradigm PressYour Money is Not SafeAmerican Alternative